CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 885 enrolled
Drug / intervention
Smart phone based patient support tool +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02433288
NCT02433288N/ACompleted
CompareCT.gov

A Randomized, Two-arm, Open, 24-week Study to Evaluate the Effect of a Smart Phone-based Patient Support Tool on Duration of Treatment in Patients Prescribed Rosuvastatin in China

AstraZeneca·interventional·Posted May 4, 2015·Updated Jan 31, 2019

In Brief

A clinical study evaluating Smart phone based patient support tool and Control application: only for data collection for Dyslipidemia and Hyperlipidemia. Completed, enrolled 885 participants across 25 sites.

Detailed Summary

This is a randomized, two-arm, open label, Phase IV clinical trial to evaluate if the provision of a smart phone-based patient support tool prolongs the patient's rosuvastatin treatment duration.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyslipidemia, Hyperlipidemia
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 4, 2015
Enrollment StartJul 20, 2015
Primary CompletionOct 28, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.2 years ago

Interventions

Smart phone based patient support toolother

The smart phone application used on the patients' smart phones will contain both the patient support tool and the questions for the clinical evaluation in the form of the Rosuvastatin Adherence questionnaire (RAQ), Beliefs about Medicine Questionnaire - General (BMQ-G), (Horne, 1999) and a Lifestyle questionnaire (LSQ) on disease understanding, lifestyle and treatment awareness. Patients in the Active group will also receive feedback on their daily rosuvastatin treatment as entered in the patient support tool.

Control application: only for data collectionother

the patients will have no access to the smart phone-based patient support tool. However, a smart phone application will be used to prompt patients with the questions for the clinical evaluation (RAQ, BMQ-G and LSQ).